Dr. Reddy's Laboratories Limited
DRREDDY · National Stock Exchange of India (NSE) · Pharmaceuticals · US listing: RDY
About the company
Dr. Reddy's Laboratories is a leading Indian pharmaceutical company that manufactures and markets generic drugs, active pharmaceutical ingredients, and biosimilars for customers in the US, India, Europe, and other markets. It is among the few Indian drug companies with a significant branded generics presence in Russia and other key emerging markets. The company has invested in biosimilars and specialty pharmaceuticals as future growth drivers.
| Exchange | National Stock Exchange of India (NSE) |
| Ticker | DRREDDY |
| Sector | Pharmaceuticals |
| US listing | RDY |
| Indicative market cap USD | $12.00B |
| Website | Visit website |
Live quote
Loading live price…
| Market cap | |
| Day range | |
| 52-week range |
Where to buy
Trades in the US as RDY — available through most US brokerage accounts.
On its home market (National Stock Exchange of India (NSE)), it is accessible through global brokers that offer that exchange:
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- National Stock Exchange of India — official exchange listing
Availability information only — not a recommendation or an offer to buy. Confirm eligibility, fees and current availability with your broker.
Other companies in India
Company data and any live price are indicative, may be delayed or inaccurate, and are for research only — not investment advice. Verify with the exchange, the company's filings and your broker.